Effects of Virtual Reality Exergaming on Reaction Time, Physical Performance, and Muscle Activity in Children
NCT07916155, Not applicable, Not yet recruiting, Babes-Bolyai University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Virtual Reality Exergaming on Reaction Time, Physical Performance, and Muscle Activity in Children | ClinicalTrials.gov |
| NCT number | NCT07916155 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 360 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Babes-Bolyai University | ClinicalTrials.gov |
| Conditions | Neuromuscular Performance, Reaction Time, Postural Balance | ClinicalTrials.gov |
| Interventions | Immersive Virtual Reality Exergaming, Immersive Virtual Reality Exergaming | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change From Baseline in Median Choice Reaction Time (Milliseconds) | Baseline (before intervention) and within 30 minutes after the assigned intervention, during the same study visit. | Choice reaction time will be measured using a computerized two-choice visual reaction time task. Following standardized familiarization, participants will complete 30 recorded trials requiring responses to visual stimuli. The median reaction time for correct responses will be calculated in milliseconds (ms). Individual change will be calculated as post-intervention minus baseline reaction time. Negative values indicate faster responses following the intervention. | ClinicalTrials.gov |
| Secondary | Change From Baseline in Five Times Sit-to-Stand Completion Time (Seconds) | Baseline (before intervention) and within 30 minutes after the assigned intervention, during the same study visit. | Functional lower-limb performance will be assessed using the Five Times Sit-to-Stand test. Participants will stand up from and sit down on a standardized chair five times as quickly as possible, with their arms crossed over the chest. Completion time will be recorded in seconds. Individual change will be calculated as post-intervention minus baseline completion time. Negative values indicate faster performance. | ClinicalTrials.gov |
| Secondary | Change From Baseline in Single-Leg Stance Balance Errors (Number of Errors per Trial) | Baseline (before intervention) and within 30 minutes after the assigned intervention, during the same study visit. | Static postural control will be assessed using a standardized single-leg stance test performed on a firm surface with eyes open and hands on hips. Participants will complete three 20-second trials on each leg. Balance errors, including touching the floor with the non-supporting foot, moving the supporting foot, or removing the hands from the hips, will be recorded. The mean number of errors per trial across six trials will be calculated. Individual change will be calculated as post-intervention minus baseline. Negative values indicate fewer balance errors. | ClinicalTrials.gov |
| Secondary | Change From Baseline in Bilateral Rectus Femoris Normalized sEMG Amplitude During Five Times Sit-to-Stand | Baseline (before intervention) and within 30 minutes after the assigned intervention, during the same study visit. | Surface electromyography (sEMG) will be recorded bilaterally from the rectus femoris during the Five Times Sit-to-Stand test. Root mean square (RMS) amplitude will be normalized to a standardized reference contraction and expressed as a percentage of the reference amplitude. Mean normalized RMS across both muscles will be calculated for each assessment. Individual change will be calculated as post-intervention minus baseline normalized RMS. | ClinicalTrials.gov |
| Other | Change From Baseline in Shank Angular Velocity Variability During Single-Leg Stance | Baseline (before intervention) and within 30 minutes after the assigned intervention, during the same study visit. | Inertial measurement units attached to the lower legs will record angular velocity during single-leg stance. The standard deviation of resultant three-dimensional shank angular speed will be calculated in degrees per second for each 20-second trial. Values will be averaged across six trials. Individual change will be calculated as post-intervention minus baseline angular velocity variability. This measure characterizes shank movement variability rather than direct center-of-pressure displacement. | ClinicalTrials.gov |
| Other | Change From Baseline in Choice Reaction Time Response Accuracy (Percentage) | Baseline (before intervention) and within 30 minutes after the assigned intervention, during the same study visit. | Response accuracy will be calculated as the percentage of correct responses across 30 recorded trials of the computerized choice reaction time task. Scores range from 0% to 100%, with higher values indicating greater accuracy. Individual change will be calculated as post-intervention minus baseline accuracy, expressed in percentage points. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 4
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Choice Reaction Time | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)